MedTrace Logo

EFFECTIVENESS OF VIRTUAL REALITY SIMULATION

NCT07663851 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-06-23

No results posted yet for this study

Summary

This randomized controlled trial aims to evaluate the effects of VRS on decision-making skills, self-confidence levels, and anxiety of psychiatric nursing students. Students participating in the study will be divided into two groups: intervention and control groups. VRS, which includes a scenario of a patient with schizophrenia, will be applied to the intervention group at the beginning of the academic term, before students start clinical practice, and in the middle of the term. The control group will be subjected to theoretical courses and clinical practice. Data will be collected using the Clinical Decision-Making, Self-Confidence, and Anxiety Scale, Personal Information Form, and Modified Simulation Effectiveness Tool. Measurements will be performed at three time points: before the simulation, in the middle of the academic term, and at the end of the academic term. In addition, debriefing sessions will be held with students participating in VRS in groups of 4-5 within the scope of the simulation process. It is expected that the findings obtained as a result of the study will make significant contributions to the literature in understanding the effects of VRS on psychiatric nursing education. At the same time, this study aims to demonstrate that this VRS, designed specifically for the Turkish language and culture, can be an effective tool to increase the self-confidence levels of psychiatric nursing students in their clinical decision-making processes and to reduce their anxiety levels within the scope of the psychiatric nursing course. The results of the study are intended to guide the development of new approaches to the use of technology in psychiatric nursing education and the integration of technology-based VRS into the psychiatric nursing curriculum.

Conditions

  • Clinical Decision Making

Interventions

OTHER

Virtual Reality Simulation

Virtual reality simulation of a patient with schizophrenia

Sponsors & Collaborators

  • Istanbul Arel University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
23 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-06-30
Completion
2026-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07663851 on ClinicalTrials.gov